Literature DB >> 31676923

Dysphagia in Progressive Supranuclear Palsy.

Heather M Clark1, Julie A G Stierwalt2, Nirubol Tosakulwong3, Hugo Botha2, Farwa Ali2, Jennifer L Whitwell4, Keith A Josephs2.   

Abstract

Progressive supranuclear palsy (PSP) is the most common Parkinson-Plus syndrome and is associated with early onset of dysphagia relative to Parkinson Disease. The current study contributes to the growing understanding of swallowing dysfunction in PSP by describing oropharyngeal swallowing characteristics in a large prospective cohort of participants with PSP employing a nationally standardized videofluoroscopy protocol and a disease severity scale developed expressly for PSP. Participants were 51 adults diagnosed with PSP. Each participant underwent a clinical interview and standardized videofluorographic assessment. Swallowing function was characterized with the Modified Barium Swallow Impairment Scale (MBSImP) and Penetration-Aspiration Scale (PAS). Variables of interest were participant-reported difficulties with liquids and/or solids; overall impression score for each of the 17 individual MBSImP components, as well as Oral Total Sum and Pharyngeal Total Sum; and PAS. Data were described with median interquartile range, counts, and proportions. Spearman's rank correlations were calculated between MBSImP scores and participant-reported indices, FOIS, and PSP Rating Scale. Approximately two-thirds of participants reported difficulties with liquids, solids, or both, although fewer than 15% reported modifying consistencies. Videofluorographic findings included predominant oral phase impairments, including back and forth rocking motion of the tongue, delayed initiation of the pharyngeal swallow, and oral residue. Pharyngeal phase impairments were relatively infrequent and comparatively mild, with the exception of reduced tongue base retraction contributing to pharyngeal residue, and mildly disrupted laryngeal vestibule closure. Disease severity correlated significantly with oral (r = .0.42, p = .0.002) and pharyngeal (r = 0.41, p = .0.003) total sum scores as well as with the oral phase components of oral transport (r = .0.33, p = .0.02) and initiation of the pharyngeal swallow (r = .0.38, p = .0.007), and PAS for thin liquids (r = .0.44, p = .0.001). The PSP Rating Scale was not more strongly correlated with swallowing impairment than has been reported for other disease severity rating scales. Dysphagia is a common complaint of patients with PSP. The current findings corroborate and expand upon those reported in the literature, detailing relatively more frequent and more severe oral phase impairments and relatively spared hyolaryngeal excursion. Further research is needed to characterize the progression of dysphagia in PSP and to determine whether dysphagia varies in character or in rate of progression across variants of PSP.

Entities:  

Keywords:  Deglutition; Deglutition disorders; Modified barium swallow; Parkinsonism; Progressive supranuclear palsy; Swallowing; Swallowing disorders

Mesh:

Year:  2019        PMID: 31676923      PMCID: PMC7192765          DOI: 10.1007/s00455-019-10073-2

Source DB:  PubMed          Journal:  Dysphagia        ISSN: 0179-051X            Impact factor:   3.438


  29 in total

Review 1.  Efficacy of exercises to rehabilitate dysphagia: A critique of the literature.

Authors:  Susan E Langmore; Jessica M Pisegna
Journal:  Int J Speech Lang Pathol       Date:  2015-03-31       Impact factor: 2.484

2.  Dysphagia in progressive supranuclear palsy: radiologic features.

Authors:  N A Leopold; M C Kagel
Journal:  Dysphagia       Date:  1997       Impact factor: 3.438

3.  Atypical progressive supranuclear palsy underlying progressive apraxia of speech and nonfluent aphasia.

Authors:  K A Josephs; B F Boeve; J R Duffy; G E Smith; D S Knopman; J E Parisi; R C Petersen; D W Dickson
Journal:  Neurocase       Date:  2005-08       Impact factor: 0.881

Review 4.  Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop.

Authors:  I Litvan; Y Agid; D Calne; G Campbell; B Dubois; R C Duvoisin; C G Goetz; L I Golbe; J Grafman; J H Growdon; M Hallett; J Jankovic; N P Quinn; E Tolosa; D S Zee
Journal:  Neurology       Date:  1996-07       Impact factor: 9.910

5.  Parkinsonism: onset, progression and mortality.

Authors:  M M Hoehn; M D Yahr
Journal:  Neurology       Date:  1967-05       Impact factor: 9.910

6.  Electrophysiologic patterns of oral-pharyngeal swallowing in parkinsonian syndromes.

Authors:  E Alfonsi; M Versino; I M Merlo; C Pacchetti; E Martignoni; G Bertino; A Moglia; C Tassorelli; G Nappi
Journal:  Neurology       Date:  2007-02-20       Impact factor: 9.910

7.  Predictors of survival in a series of clinically diagnosed progressive supranuclear palsy patients.

Authors:  Claudia dell'Aquila; Stefano Zoccolella; Valentina Cardinali; Michele de Mari; Giovanni Iliceto; Bruno Tartaglione; Paolo Lamberti; Giancarlo Logroscino
Journal:  Parkinsonism Relat Disord       Date:  2013-08-19       Impact factor: 4.891

8.  Ultrasound imaging distinguishes between normal and weak muscle.

Authors:  Gloria Chi-Fishman; Jeanne E Hicks; Holly M Cintas; Barbara C Sonies; Lynn H Gerber
Journal:  Arch Phys Med Rehabil       Date:  2004-06       Impact factor: 3.966

Review 9.  The Unified Parkinson's Disease Rating Scale (UPDRS): status and recommendations.

Authors: 
Journal:  Mov Disord       Date:  2003-07       Impact factor: 10.338

10.  Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria.

Authors:  Günter U Höglinger; Gesine Respondek; Maria Stamelou; Carolin Kurz; Keith A Josephs; Anthony E Lang; Brit Mollenhauer; Ulrich Müller; Christer Nilsson; Jennifer L Whitwell; Thomas Arzberger; Elisabet Englund; Ellen Gelpi; Armin Giese; David J Irwin; Wassilios G Meissner; Alexander Pantelyat; Alex Rajput; John C van Swieten; Claire Troakes; Angelo Antonini; Kailash P Bhatia; Yvette Bordelon; Yaroslau Compta; Jean-Christophe Corvol; Carlo Colosimo; Dennis W Dickson; Richard Dodel; Leslie Ferguson; Murray Grossman; Jan Kassubek; Florian Krismer; Johannes Levin; Stefan Lorenzl; Huw R Morris; Peter Nestor; Wolfgang H Oertel; Werner Poewe; Gil Rabinovici; James B Rowe; Gerard D Schellenberg; Klaus Seppi; Thilo van Eimeren; Gregor K Wenning; Adam L Boxer; Lawrence I Golbe; Irene Litvan
Journal:  Mov Disord       Date:  2017-05-03       Impact factor: 10.338

View more
  6 in total

Review 1.  Autonomic dysfunction in progressive supranuclear palsy.

Authors:  Francesca Baschieri; Maria Vitiello; Pietro Cortelli; Giovanna Calandra-Buonaura; Francesca Morgante
Journal:  J Neurol       Date:  2022-08-30       Impact factor: 6.682

2.  The Burden of Progressive Supranuclear Palsy on Patients, Caregivers, and Healthcare Systems by PSP Phenotype: A Cross-Sectional Study.

Authors:  Demetris Pillas; Alexander Klein; Teresa Gasalla; Andreja Avbersek; Alexander Thompson; Jack Wright; Jennifer Mellor; Anna Scowcroft
Journal:  Front Neurol       Date:  2022-07-04       Impact factor: 4.086

3.  Eye movements and association with regional brain atrophy in clinical subtypes of progressive supranuclear palsy.

Authors:  Ji-Hyun Choi; Heejung Kim; Jung Hwan Shin; Jee-Young Lee; Han-Joon Kim; Jong-Min Kim; Beomseok Jeon
Journal:  J Neurol       Date:  2020-09-21       Impact factor: 4.849

Review 4.  The Role of the Cerebellum in Swallowing.

Authors:  Ayodele Sasegbon; Shaheen Hamdy
Journal:  Dysphagia       Date:  2021-03-06       Impact factor: 3.438

Review 5.  Protocols and assessment procedures in fiberoptic endoscopic evaluation of swallowing: an updated systematic review.

Authors:  Aline Prikladnicki; Márcia Grassi Santana; Maria Cristina Cardoso
Journal:  Braz J Otorhinolaryngol       Date:  2021-04-02

Review 6.  Best Practices in the Clinical Management of Progressive Supranuclear Palsy and Corticobasal Syndrome: A Consensus Statement of the CurePSP Centers of Care.

Authors:  Brent Bluett; Alexander Y Pantelyat; Irene Litvan; Farwa Ali; Diana Apetauerova; Danny Bega; Lisa Bloom; James Bower; Adam L Boxer; Marian L Dale; Rohit Dhall; Antoine Duquette; Hubert H Fernandez; Jori E Fleisher; Murray Grossman; Michael Howell; Diana R Kerwin; Julie Leegwater-Kim; Christiane Lepage; Peter Alexander Ljubenkov; Martina Mancini; Nikolaus R McFarland; Paolo Moretti; Erica Myrick; Pritika Patel; Laura S Plummer; Federico Rodriguez-Porcel; Julio Rojas; Christos Sidiropoulos; Miriam Sklerov; Leonard L Sokol; Paul J Tuite; Lawren VandeVrede; Jennifer Wilhelm; Anne-Marie A Wills; Tao Xie; Lawrence I Golbe
Journal:  Front Neurol       Date:  2021-07-01       Impact factor: 4.003

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.